Non Specific Shoulder Pain. Pain in unspecified shoulder
Conditions
Interventions
Intervention 1: Intervention group: Subcutaneous injection (mesotherapy) of 1 ml piroxicam 20 mg/ml with 4 ml lidocaine 2% is applied in tender points of the affected shoulder and around the affected
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients over 18 years of age Male or Female gender Completing and signing the informed consent form Patients with shoulder pain lasted more than 4 weeks and with a shoulder pain Visual Analog Scale (VAS) score of at least 4 in a recent month Absence of any disease around the affected shoulder joint
Exclusion criteria
Exclusion criteria: Any pathology found on plain radiograph such as degenerative findings of the shoulder joint Any clinical signs of effusion, inflammation, redness and warmth of the affected shoulder Diabetes Mellitus Uncontrolled Hypertension Rheumatic and Collagen Vascular Diseases such as Lupus and Gout Concomitant Radiculopathy (cervical radiculopathy), Myopathy, Nerve injuries and Neuropathies (including CTS) Stroke Any serious systemic and local infection Brucellosis BMI above 42 History of shoulder joint replacement on the affected side History of shoulder trauma and fracture and severe deformities of the upper limbs Bleeding tendency and bleeding disorders and/or use of anticoagulants Inability to communicate and complete questionnaires (Mental and Psychological problems) History of allergies and allergic reactions to the used drugs including piroxicam, corticosteroids and lidocaine History of significant liver, kidney, brain and cardiopulmonary disorders History of intraarticular or periarticular injections at the affected shoulder joint in the last 3 months History of shoulder and upper limb physiotherapy (physical therapy) in the last 1 month Pregnant and Lactating women Patients with Cancer or Malignancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Shoulder pain. Timepoint: Before intervention; two weeks, four weeks, eight weeks and twelve weeks later. Method of measurement: Visual Analogue Scale; Oxford Shoulder Score. | — |
Secondary
| Measure | Time frame |
|---|---|
| Function of patient. Timepoint: Before intervention; two weeks, four weeks, eight weeks and twelve weeks later. Method of measurement: Oxford Shoulder Score. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Hossein Jabbedari
Shiraz University of Medical Sciences
Outcome results
None listed